These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9606468)

  • 1. Phenotypic involvement in females with the FMR1 gene mutation.
    Riddle JE; Cheema A; Sobesky WE; Gardner SC; Taylor AK; Pennington BF; Hagerman RJ
    Am J Ment Retard; 1998 May; 102(6):590-601. PubMed ID: 9606468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular/clinical correlations in females with fragile X.
    Sobesky WE; Taylor AK; Pennington BF; Bennetto L; Porter D; Riddle J; Hagerman RJ
    Am J Med Genet; 1996 Aug; 64(2):340-5. PubMed ID: 8844077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
    Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
    JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific methylation differences and cognitive function in fragile X premutation females.
    Allingham-Hawkins DJ; Brown CA; Babul R; Chitayat D; Krekewich K; Humphries T; Ray PN; Teshima IE
    Am J Med Genet; 1996 Aug; 64(2):329-33. PubMed ID: 8844075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A neuropsychological investigation of male premutation carriers of fragile X syndrome.
    Moore CJ; Daly EM; Schmitz N; Tassone F; Tysoe C; Hagerman RJ; Hagerman PJ; Morris RG; Murphy KC; Murphy DG
    Neuropsychologia; 2004; 42(14):1934-47. PubMed ID: 15381024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the FMR1 gene mutation to human intellectual dysfunction.
    Reiss AL; Freund LS; Baumgardner TL; Abrams MT; Denckla MB
    Nat Genet; 1995 Nov; 11(3):331-4. PubMed ID: 7581460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound heterozygosity at the FMR1 gene.
    Hegde MR; Fawkner M; Chong B; McGaughran J; Gilbert D; Love DR
    Genet Test; 2001; 5(2):135-8. PubMed ID: 11551100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FMR1 and the fragile X syndrome: human genome epidemiology review.
    Crawford DC; Acuña JM; Sherman SL
    Genet Med; 2001; 3(5):359-71. PubMed ID: 11545690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the fragile X (FRAXA) syndrome with methylation-sensitive PCR.
    Weinhäusel A; Haas OA
    Hum Genet; 2001 Jun; 108(6):450-8. PubMed ID: 11499669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription of the FMR1 gene in individuals with fragile X syndrome.
    Tassone F; Hagerman RJ; Chamberlain WD; Hagerman PJ
    Am J Med Genet; 2000; 97(3):195-203. PubMed ID: 11449488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A female compound heterozygote (pre- and full mutation) for the CGG FMR1 expansion.
    Milà M; Castellví-Bel S; Giné R; Vazquez C; Badenas C; Sánchez A; Estivill X
    Hum Genet; 1996 Oct; 98(4):419-21. PubMed ID: 8792815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy.
    Moore CJ; Daly EM; Tassone F; Tysoe C; Schmitz N; Ng V; Chitnis X; McGuire P; Suckling J; Davies KE; Hagerman RJ; Hagerman PJ; Murphy KC; Murphy DG
    Brain; 2004 Dec; 127(Pt 12):2672-81. PubMed ID: 15483045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A distinct neurocognitive phenotype in female fragile-X premutation carriers assessed with visual attention tasks.
    Steyaert J; Legius E; Borghgraef M; Fryns JP
    Am J Med Genet A; 2003 Jan; 116A(1):44-51. PubMed ID: 12476450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging fragile X premutation phenotype: evidence from the domain of social cognition.
    Cornish K; Kogan C; Turk J; Manly T; James N; Mills A; Dalton A
    Brain Cogn; 2005 Feb; 57(1):53-60. PubMed ID: 15629215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.
    Jacquemont S; Hagerman RJ; Leehey MA; Hall DA; Levine RA; Brunberg JA; Zhang L; Jardini T; Gane LW; Harris SW; Herman K; Grigsby J; Greco CM; Berry-Kravis E; Tassone F; Hagerman PJ
    JAMA; 2004 Jan; 291(4):460-9. PubMed ID: 14747503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical involvement and protein expression in individuals with the FMR1 premutation.
    Tassone F; Hagerman RJ; Taylor AK; Mills JB; Harris SW; Gane LW; Hagerman PJ
    Am J Med Genet; 2000 Mar; 91(2):144-52. PubMed ID: 10748416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragile-X syndrome and skewed X-chromosome inactivation within a family: a female member with complete inactivation of the functional X chromosome.
    Heine-Suñer D; Torres-Juan L; Morlà M; Busquets X; Barceló F; Picó G; Bonilla L; Govea N; Bernués M; Rosell J
    Am J Med Genet A; 2003 Oct; 122A(2):108-14. PubMed ID: 12955761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families.
    Geva E; Yaron Y; Shomrat R; Ben-Yehuda A; Zabari S; Peretz H; Naiman T; Yeger H; Orr-Urtreger A
    Genet Test; 2000; 4(3):289-92. PubMed ID: 11142761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the FMR1 gene.
    Tassone F; Hagerman PJ
    Cytogenet Genome Res; 2003; 100(1-4):124-8. PubMed ID: 14526172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fragile X premutation: into the phenotypic fold.
    Hagerman RJ; Hagerman PJ
    Curr Opin Genet Dev; 2002 Jun; 12(3):278-83. PubMed ID: 12076670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.